AKT1 and hepatocellular carcinoma: In a highly metastatic hepatocellular carcinoma cell line SMMC-7721, Sulf-1 was reported to have inhibited complex formation between hepatocyte growth factor ligand and tyrosine kinase receptor c-met [15] and this further inhibited the activation of ERK, PI3K/AKT pathway.